What’s New + In The News

  • New Zealand Reverse-Switches Codeine Judging Risks Outweigh Benefits December 11, 2019
    New Zealand is the latest country to reverse-switch all codeine-containing OTC drugs to prescription-only status following a protracted consultation process...      Related StoriesSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed ThreeHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Tom Gallen
  • Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint December 11, 2019
    The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsUS Senate Passes First Monograph Reform Bill After House Passed ThreeHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Malcolm Spicer
  • US Senate Passes First Monograph Reform Bill After House Passed Three December 11, 2019
    Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Malcolm Spicer
  • Homeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve December 11, 2019
    FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Eileen Francis
  • Industry Ignored In Dispute Over UK Retailer’s ‘Weight Management’ Claim December 10, 2019
    Despite being defended by four industry representative bodies, UK health food retailer Holland & Barrett has been rapped for its...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    David Ridley
  • BREAKING: Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off? December 10, 2019
    Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Tom Gallen
  • Cosmetics Weekly Trademark Review: 3 December 2019 December 10, 2019
    Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Ryan Nelson
  • More Ranitidine Products, Altaire Eye Drops Among Recent OTC Recalls December 10, 2019
    Recent updates to FDA recalls database also include single lots of three package sizes of Johnson’s Baby Powder after testing...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Malcolm Spicer
  • Switzerland Provides Gateway Into Mainland Europe For BASF’s Hepacor December 9, 2019
    With the Swiss launch of its Non-Alcoholic Fatty Liver Disease supplement, BASF is looking to make inroads into continental Europe.       Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    David Ridley
  • Sanofi Personalizing IBS Treatment With Digital Therapy December 9, 2019
    Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Tom Gallen
  • New Zealand Reverse-Switches Codeine Judging Risks Outweigh Benefits December 11, 2019
    New Zealand is the latest country to reverse-switch all codeine-containing OTC drugs to prescription-only status following a protracted consultation process...      Related StoriesSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed ThreeHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Tom Gallen
  • Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint December 11, 2019
    The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsUS Senate Passes First Monograph Reform Bill After House Passed ThreeHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Malcolm Spicer
  • US Senate Passes First Monograph Reform Bill After House Passed Three December 11, 2019
    Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Malcolm Spicer
  • Homeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve December 11, 2019
    FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Eileen Francis
  • Industry Ignored In Dispute Over UK Retailer’s ‘Weight Management’ Claim December 10, 2019
    Despite being defended by four industry representative bodies, UK health food retailer Holland & Barrett has been rapped for its...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    David Ridley
  • BREAKING: Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off? December 10, 2019
    Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Tom Gallen
  • Cosmetics Weekly Trademark Review: 3 December 2019 December 10, 2019
    Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Ryan Nelson
  • More Ranitidine Products, Altaire Eye Drops Among Recent OTC Recalls December 10, 2019
    Recent updates to FDA recalls database also include single lots of three package sizes of Johnson’s Baby Powder after testing...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Malcolm Spicer
  • Switzerland Provides Gateway Into Mainland Europe For BASF’s Hepacor December 9, 2019
    With the Swiss launch of its Non-Alcoholic Fatty Liver Disease supplement, BASF is looking to make inroads into continental Europe.       Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    David Ridley
  • Sanofi Personalizing IBS Treatment With Digital Therapy December 9, 2019
    Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Tom Gallen
  • New Zealand Reverse-Switches Codeine Judging Risks Outweigh Benefits December 11, 2019
    New Zealand is the latest country to reverse-switch all codeine-containing OTC drugs to prescription-only status following a protracted consultation process...      Related StoriesSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed ThreeHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Tom Gallen
  • Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint December 11, 2019
    The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsUS Senate Passes First Monograph Reform Bill After House Passed ThreeHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Malcolm Spicer
  • US Senate Passes First Monograph Reform Bill After House Passed Three December 11, 2019
    Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintHomeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve 
    Malcolm Spicer
  • Homeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve December 11, 2019
    FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Eileen Francis
  • Industry Ignored In Dispute Over UK Retailer’s ‘Weight Management’ Claim December 10, 2019
    Despite being defended by four industry representative bodies, UK health food retailer Holland & Barrett has been rapped for its...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    David Ridley
  • BREAKING: Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off? December 10, 2019
    Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Tom Gallen
  • Cosmetics Weekly Trademark Review: 3 December 2019 December 10, 2019
    Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Ryan Nelson
  • More Ranitidine Products, Altaire Eye Drops Among Recent OTC Recalls December 10, 2019
    Recent updates to FDA recalls database also include single lots of three package sizes of Johnson’s Baby Powder after testing...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Malcolm Spicer
  • Switzerland Provides Gateway Into Mainland Europe For BASF’s Hepacor December 9, 2019
    With the Swiss launch of its Non-Alcoholic Fatty Liver Disease supplement, BASF is looking to make inroads into continental Europe.       Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    David Ridley
  • Sanofi Personalizing IBS Treatment With Digital Therapy December 9, 2019
    Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which...      Related StoriesNew Zealand Reverse-Switches Codeine Judging Risks Outweigh BenefitsSupreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade ComplaintUS Senate Passes First Monograph Reform Bill After House Passed Three 
    Tom Gallen